Although international medical graduates comprise a significant portion of practicing oncologists in the United States (US), their research contributions as hematology/oncology fellows have been poorly understood historically, and structural barriers persist in terms of matching into suitable fellowships and residencies, according to Arya Mariam Roy, MD, MBBS.
During the 2025 ASCO Annual Meeting, Roy presented findings from a retrospective study, which examined the research productivity of international medical graduates during hematology/oncology fellowship.1 Findings from the study demonstrated that international medical graduates produced higher research productivity vs American medical graduates during fellowship in terms of the median numbers of abstracts, Google scholar articles, total manuscripts, first author manuscripts, high-impact journal articles, original articles, and review articles (all P < .001).
Research Productivity of International Medical Graduate Hematology/Oncology Fellows in the US: Key Takeaways
- International medical graduates comprise approximately 25% of all practicing physicians and approximately 33% of all practicing oncologists in the US.
- Despite this, international medical graduates face significant barriers in terms of findings suitable fellowship and residency programs.
- Findings from a retrospective study showed that international medical graduates produced higher research productivity vs American medical graduates during fellowship in terms of the median numbers of abstracts, Google scholar articles, total manuscripts, first author manuscripts, high-impact journal articles, original articles, and review articles (all P < .001).
“International medical graduates make vital contributions to academic medicine,” Roy, an assistant professor in the Division of Oncology at The Ohio State University College of Medicine in Columbus, said in an interview with Oncology Fellows. “There is a need to address potential structural barriers, which prevent them [from practicing] at US academic institutions. [This study] is a stepping stone, and we are doing more research in this area.”
In the interview, Roy discussed the rationale for the study, the key findings, and how the study results can be used to break down the barriers that international medical graduates often face.
Oncology Fellows: What prompted the initiation of this study?
Roy: [Approximately] 25% of all practicing physicians in the US are international medical graduates.2 International medical graduates also account for [approximately] one-third of all practicing oncologists in the US.3 However, [although] we are represented in the oncology workforce, we see that it’s hard for international medical graduates to match into good residency and fellowship programs in the US. Even if they have good credentials, exam scores, and a CV with good publications, it’s hard to get matched into good fellowship programs or residency programs.
That’s where the importance of this project [lies] because we are trying to [determine] the academic productivity of international medical graduate hematology/oncology fellows and compare that with the academic productivity of American medical graduates. The main idea behind this project is that if we identify that international medical graduate hematology/oncology fellows are more productive in terms of their academic [publications] compared with American medical graduates, we can use this as a metric for recruiting more international medical graduate fellows into fellowship.